BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36256619)

  • 1. Cross-reactive inhibitory antibody and memory B cell responses to variant strains of Duffy binding protein II at post-Plasmodium vivax infection.
    Thawornpan P; Changrob S; Kochayoo P; Wangriatisak K; Ntumngia FB; De SL; Han ET; Adams JH; Chootong P
    PLoS One; 2022; 17(10):e0276335. PubMed ID: 36256619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain-Transcending Inhibitory Antibodies against Homologous and Heterologous Strains of Duffy Binding Protein region II.
    Wongkidakarn S; McHenry AM; Sattabongkot J; Adams JH; Chootong P
    PLoS One; 2016; 11(5):e0154577. PubMed ID: 27145131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of Long-lived Memory B Cells specific to Duffy Binding Protein in individuals exposed to Plasmodium vivax.
    Changrob S; McHenry AM; Nyunt MH; Sattabongkot J; Han ET; Adams JH; Chootong P
    Sci Rep; 2018 May; 8(1):8347. PubMed ID: 29844379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
    Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of Duffy binding protein region II polymorphisms and its antigenicity in Plasmodium vivax isolates from Thailand.
    Chootong P; McHenry AM; Ntumngia FB; Sattabongkot J; Adams JH
    Parasitol Int; 2014 Dec; 63(6):858-64. PubMed ID: 25108177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.
    George MT; Schloegel JL; Ntumngia FB; Barnes SJ; King CL; Casey JL; Foley M; Adams JH
    mSphere; 2019 May; 4(3):. PubMed ID: 31092602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand.
    Chootong P; Panichakul T; Permmongkol C; Barnes SJ; Udomsangpetch R; Adams JH
    PLoS One; 2012; 7(4):e35769. PubMed ID: 22558221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period.
    Medeiros CMP; Moreira EUM; Pires CV; Torres LM; Guimarães LFF; Alves JRS; Lima BAS; Fontes CJF; Costa HL; Brito CFA; Sousa TN; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
    PLoS One; 2020; 15(5):e0232786. PubMed ID: 32379804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed Microsphere-Based Flow Cytometric Assay to Assess Strain Transcending Antibodies to
    Alves JRS; de Araújo FF; Pires CV; Teixeira-Carvalho A; Lima BAS; Torres LM; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
    Front Immunol; 2021; 12():704653. PubMed ID: 34675915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein (PvDBP-II) equally block erythrocyte binding of homologous and heterologous expressed PvDBP-II on the surface of COS-7 cells.
    Valizadeh V; Zakeri S; Mehrizi AA; Mirkazemi S; Djadid ND
    Med Microbiol Immunol; 2016 Feb; 205(1):85-95. PubMed ID: 26243337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission.
    Valizadeh V; Zakeri S; Mehrizi AA; Djadid ND
    Acta Trop; 2014 Aug; 136():89-100. PubMed ID: 24704284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein.
    Ntumngia FB; Adams JH
    Clin Vaccine Immunol; 2012 Jan; 19(1):30-6. PubMed ID: 22116684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Barnes SJ; McHenry AM; George MT; Schloegel J; Adams JH
    Clin Vaccine Immunol; 2014 Sep; 21(9):1215-23. PubMed ID: 24964808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants.
    Kano FS; Souza-Silva FA; Torres LM; Lima BA; Sousa TN; Alves JR; Rocha RS; Fontes CJ; Sanchez BA; Adams JH; Brito CF; Pires DE; Ascher DB; Sell AM; Carvalho LH
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005177. PubMed ID: 27959918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Characterization of Functional Human Monoclonal Antibodies to
    Carias LL; Dechavanne S; Nicolete VC; Sreng S; Suon S; Amaratunga C; Fairhurst RM; Dechavanne C; Barnes S; Witkowski B; Popovici J; Roesch C; Chen E; Ferreira MU; Tolia NH; Adams JH; King CL
    J Immunol; 2019 May; 202(9):2648-2660. PubMed ID: 30944159
    [No Abstract]   [Full Text] [Related]  

  • 16. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
    King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.
    Ntumngia FB; King CL; Adams JH
    Int J Parasitol; 2012 Nov; 42(12):1055-62. PubMed ID: 23068913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
    Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK
    mBio; 2019 Oct; 10(5):. PubMed ID: 31594821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acquisition of long-lived memory B cell responses to merozoite surface protein-8 in individuals with Plasmodium vivax infection.
    Kochayoo P; Kittisenachai N; Changrob S; Wangriatisak K; Muh F; Chootong P; Han ET
    Malar J; 2019 May; 18(1):188. PubMed ID: 31151441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.